1. Effects of Curcuminoids on Systemic Inflammation and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy: a Randomized Controlled Trial
2. Curcumin and Piperine Combination for the Treatment of Patients with Non-alcoholic Fatty Liver Disease: a Double-Blind Randomized Placebo-Controlled Trial
3. Evaluation of the Effects of Nanomicellar Curcumin, Berberine and their Combination with 5-fluorouracilon Breast Cancer Cells
4. The effect of herbal medicine and natural bioactive compounds on plasma adiponectin: a clinical review
5. The effects of nutraceuticals and bioactive natural compounds on chronic periodontitis: a clinical review
6. The multifaceted actions of curcumin in obesity
7. Antiviral plants in view of Avicenna's Canon of Medicine and modern medicine against common cold
8. Antifungal activity of curcuminoids and difluorinated curcumin against clinical isolates of Candida species
9. Investigation of the effects of difluorinated curcumin on glycemic indices in streptozotocin- induced diabetic rats
10. Evaluation of the Effect of Crocin on Doxorubicin-Induced Cardiotoxicity
11. The role of chemokines in cardiovascular diseases and the therapeutic effect of curcumin on CXCL8 and CCL2 as pathological chemokines in atherosclerosis
12. Health benefits of turmeric and curcumin against food contaminants
13. The effects of curcumin plus piperine supplementation in patients with acute myocardial infarction: a randomized, double-blind and placebo-controlled trial
14. Protective effects of curcumin on pulmonary arterial hypertension
15. Protective effects of curcumin in the reproductive system: anti-toxic, semen cryopreservative and contraceptive actions
16. Protective effects of curcumin phytosomes against high-fat diet-induced atherosclerosis
17. The effects of curcumin on the side effects of anticancer drugs in chemotherapy: A randomized controlled trial
18. Crocin Improves Diabetes-Induced Oxidative Stress via Down-Regulating the Nox-4 in Myocardium of Diabetic Rats
19. Role of herbal medicines in the management of brain injury
20. The effects of ginsenosides on the Nrf2 signaling pathway
21. The effect of green coffee bean extract on cardiovascular risk factors: A systematic review and meta-analysis
22. Nanomicellar curcumin supplementation improves the clinical manifestations of HAM/TSP patients
23. The effects of Ivy (Hedera helix) on respiratory problems and cough in humans: a review
24. Safety and efficacy of oral supplementation of lentil (Lens culinaris Medic) in dry eye patients
25. A review of Glycyrrhiza Glabra (Licorice) effects on Metabolic Syndrome
26. Natural insulin sensitizers for the management of diabetes mellitus: a review of possible molecular mechanisms
27. Evaluation of the anti-constipation effects of abdominal application of olive oil ointment in children 1-4 years old: A pilot placebo-controlled, double-blind, randomized clinical trial
28. Therapeutic Potential of Pomegranate in Metabolic Disorders
29. Resveratrol as a Probable Multi-headed Treatment approach for COVID-19
30. A review on the phytochemistry, pharmacology, and therapeutic effects of Rheum ribes
31. Anti-tumor and protective effects of melatonin: the potential roles of microRNAs
32. Antioxidant effects of trehalose in an experimental model of type 2 diabetes
33.
About the Author:
Amirhossein Sahebkar, PharmD., PhD., is Associate Professor of Pharmaceutical Biotechnology in the School of Pharmacy at the Mashhad University of Medical Sciences in Iran, and Honorary Research Fellow in the School of Health and Medical Sciences at the University of Western Australia. He has published more than 1100 articles on areas including blood lipids, neurovascular diseases, modern medical treatments in cellular, molecular, and animal tissues, and atherosclerosis. He is a highly cited researcher in the field of Pharmacology and Toxicology and has an h-index of 85.
Thozhukat Sathyapalan, MD., FRCP., FACP., is the Chair in Academic Diabetes, Endocrinology and Metabolism in Hull York Medical School, University of Hull and Honorary Consultant Endocrinologist at Hull and East Yorkshire Hospitals NHS Trust, United Kingdom. His main area of interest is on modulation of cardiometabolic risk through pharmacological and nutritional interventions. He has conducted several clinical trials in this area. He has also published and presented extensively in this field.
